DEUTSCHE BANK AG\ - SPRING BK PHARMACEUTICALS IN ownership

SPRING BK PHARMACEUTICALS IN's ticker is SBPH and the CUSIP is 849431101. A total of 52 filers reported holding SPRING BK PHARMACEUTICALS IN in Q2 2018. The put-call ratio across all filers is - and the average weighting 0.1%.

Quarter-by-quarter ownership
DEUTSCHE BANK AG\ ownership history of SPRING BK PHARMACEUTICALS IN
ValueSharesWeighting
Q4 2019$055
-45.0%
0.00%
Q3 2019$0
-100.0%
100
-99.8%
0.00%
Q2 2019$161,000
-12.0%
44,100
+152.0%
0.00%
Q1 2019$183,000
-2.1%
17,502
-3.5%
0.00%
Q4 2018$187,000
-74.6%
18,136
-70.4%
0.00%
Q3 2018$736,000
+59.7%
61,242
+57.0%
0.00%
Q2 2018$461,000
+3741.7%
39,005
+4775.6%
0.00%
Q1 2018$12,000
-88.0%
800
-89.3%
0.00%
Q4 2017$100,000
-80.9%
7,500
-75.9%
0.00%
Q3 2017$523,000
+80.3%
31,100
+45.1%
0.00%
Q2 2017$290,00021,435
+21335.0%
0.00%
Q1 2017$01000.00%
Other shareholders
SPRING BK PHARMACEUTICALS IN shareholders Q2 2018
NameSharesValueWeighting ↓
PARSONS CAPITAL MANAGEMENT INC/RI 195,165$1,559,0000.21%
DAFNA Capital Management LLC 27,412$219,0000.19%
Verity & Verity, LLC 12,385$99,0000.03%
Baker Brothers Advisors 219,298$1,752,0000.02%
Alyeska Investment Group, L.P. 200,000$1,598,0000.01%
Alyeska Investment Group, L.P. 200,000$1,598,0000.01%
SILVERCREST ASSET MANAGEMENT GROUP LLC 97,286$777,0000.01%
BRYN MAWR TRUST Co 14,000$112,0000.01%
BlackRock Investment Management, LLC 163$1,0000.00%
MORGAN STANLEY 12,500$100,0000.00%
View complete list of SPRING BK PHARMACEUTICALS IN shareholders